Synthesis, characterization and biological studies of substituted quinozoline-4-(3H)-ones containing diazepine moiety

Annales Pharmaceutiques Francaises

Volumn 72, Issue 1, 2014, Pages 51-58

  Narayana Rao, D V ^a   Raghavendra Guru Prasad, A ^b   Spoorthy, Y N ^a   Pariplavi, M ^c   Ravindranath, L K ^a  

^a SRI KRISHNADEVARAYA UNIVERSITY   (India)

^b IFHE University   (India)

^c OSMANIA MEDICAL COLLEGE   (India)

Author keywords

1,4 benzodiazepine; Anthelmintic activity; Antimicrobial activity; Structural characterization

Indexed keywords

BENZODIAZEPINE DERIVATIVE; ANTHELMINTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; QUINAZOLINE DERIVATIVE;

ANTHELMINTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS CEREUS; CANDIDA ALBICANS; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; METAPHIRE POSTHUMA; MICROORGANISM; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFRARED SPECTROPHOTOMETRY; MICROBIAL SENSITIVITY TEST; NUCLEAR MAGNETIC RESONANCE; OLIGOCHAETA; SYNTHESIS;

ANIMALS; ANTHELMINTICS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ASPERGILLUS NIGER; BENZODIAZEPINONES; CANDIDA ALBICANS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOCHAETA; QUINAZOLINES; SPECTROPHOTOMETRY, INFRARED;

EID: 84892491938     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2013.11.001     Document Type: Article

References (25)

1. Sternbach L.H., Randall L.O., Banziger R.F., Lehr H., Burger A. Drugs affecting the central nervous systems. Medicinal research Series 1969, vol. 2. Marcal Dekker Inc, New York.
2. Deck P., Pendzialek D., Biel M., Wagner M., Popkirova B., Ludolph B., et al. Development and biological evaluation of acyl protein thioesterase 1 (APT1) inhibitors. Angew Chem Int Ed Engl 2005, 44:4975-4980.
3. Wattanasin S., Kallen J., Myers S., Guo Q., Sabio M., Ehrhardt C., et al. 1,4-diazepane-2,5-diones as novel inhibitors of LFA-1. Bioorg Med Chem Lett 2005, 15:1217-1220.
4. Hanna L., Wanda P.N., Barbara S., Joanna W., Joanna J., Anna N., et al. Synthesis and antiproliferative activity in vitro of new pyrido[1,4-b]diazepine derivatives and imidazo[4,5-b]pyridine. Acta Poloniae Pharm Drug Res 2011, 68:349-355.
5. Hunt J.T., Ding C.Z., Batorsky R., Bednarz M., Bhide R., Cho Y., et al. Discovery of (R)-7-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4 benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity. J Med Chem 2000, 43:3587-3595.
6. Carter M.C., Alber D.G., Baxter R.C., Bithell S.K., Budworth J., Chubb A., et al. 1,4-benzodiazepines as inhibitors of respiratory syncytial virus. J Med Chem 2006, 49:2311-2319.
7. Churcher I., Williams S., Kerrad S., Harrison T., Castro J.L., Shearman M.S., et al. Design and synthesis of highly potent benzodiazepine gamma-secretase inhibitors: preparation of (2S,3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4-hydroxy-N-(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement. J Med Chem 2003, 46:2275-2278.
8. Lauffer D.J., Mullican M.D. A practical synthesis of (S) 3-tert-butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic acid methyl ester as a conformationally restricted dipeptido-mimetic for caspase-1 (ICE) inhibitors. Bioorg Med Chem Lett 2002, 12:1225-1227.
9. Pellegrini M., Weitz I.S., Chorev M., Mierke D.F. A trisubstituted 1,4-diazepine-3-one-based dipeptidomimetic:conformational characterization by NMR and computer simulation. J Am Chem Soc 1997, 119:2430-2436.
10. Rajesh K., Yogesh Chandra J. Synthesis, antimicrobial and antifungal activities of novel 1H-1,4-diazepines containing pyrazolopyrimidinone moiety. J Chem Sci 2009, 121:497-502.
11. Raboisson P., Marugan J.J., Schubert C., Koblish H.K., Lu T., Zhao S., et al. Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists. Bioorg Med Chem Lett 2005, 15:1857-1861.
12. Gorlitzer K., Wolpert C., Rubsamen-Waigmann H., Suhartono H., Wang L., Immelmann A. Pyrido(3,2-e)(1,4)diazepines-synthesis and testing of anti-HIV-1 activity. Arch Pharm (Weinheim) 1995, 328:247-255.
13. Alagarsamy V., Giridhar R., Yadav M.R., Revathi R., Rukmani K., Clercq D.E. Anti-HIV, antibacterial, antifungal activities of some novel 1,4-disubstituted-1,2,4-triazolo [4,3-a] quinazolin-5(4H)-ones. Indian J Pharm Sci 2006, 68:532-535.
14. Farghaly A.M., Chaabanm I., Khalil M.A., Bekhit A.A. Non-steroidal antiinflammatory agents, II: synthesis of novel pyrazole and pyrazoline derivatives of 4(3H)-quinazolinone. Arch Pharm (Weinheim) 1990, 323:311-315.
15. Jessy E.M., Thirugnana A.S., Alex J., Sridevi C.H., Srinivasan K.K. Synthesis and biological evaluation of some novel quinazolines. Indian J Pharm Sci 2007, 69:476-478.
16. Jung S.Y., Lee S.H., Kang H.B., Park H.A., Chang S.K., Kim J., et al. Antitumor activity of 3,4-dihydroquinazoline dihydrochloride in A549 xenograft nude mice. Bioorg Med Chem Lett 2010, 20:6633-6636.
17. Nessar I.E. Synthesis of some quinazolines derived from 6,8-dibromo-2-(2-carboxy-phenyl)-4H-3,1-benzoxazin-4-one as antimicrobial agents. Chem Heterocyclic Compounds 2009, 45:1515-1522.
18. Pattan S.R., Krishna Reddy V.V., Manvi F.V., Desai B.G., Bhat A.R. Synthesis of N-3(4-(4-chlorophenylthia-zole-2-yl))-(2-(amino)methyl)-quinazoline-4(3H)-one and their derivatives for antitubercular activity. Indian J Chem 2006, 45B:1778-1781.
19. Raghavendra N.M., Thampi P., Gurubasavarajaswamy P.M., Sriram D. Synthesis, antitubercular and anticancer activities of substituted furyl-quinazolin-3(4H)-ones. Arch Pharm 2007, 340:635-641.
20. Yahia A.M., Abd El-Galil E.A., Salwa F.M., Mohamed M.A., Al-Omar A.M., Samira H.S. Cytotoxicity and anti-HIV evaluations of some new synthesized quinazoline and thioxopyrimidine derivatives using 4-(thiophen-2-yl)-3,4,5,6-tetrahydrobenzo[h]quinazoline-2(1H)-thione as synthon. J Chem Sci 2012, 124:693-702.
21. Wiegand I., Hilpert K., Hancock R.E. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 2008, 3:163-175.
22. Joshi Y.C., Shalini S., Kavita P.J., Rajesh K. Silica sulfuric acid as a mild and efficient reagent for the synthesis of 1,4-diazepine and 1,5-benzodiazepine derivatives. J Korean Chem Soc 2011, 55:630-643.
23. Vigar Z. Atlas of Medical Parasitology 1984, P.G. Publishing House, Singapore. 2nd ed.
24. Dash G.K., Suresh P., Kar D.M., Ganpaty S., Panda S.B. Evaluation of Evolvulus alsinoides Linn. for anthelmintic and antimicrobial activities. J Nat Rem 2002, 2:182-185.
25. Shiv Kumar Y.M., Kumar V.L. Anthelmintic activity of latex of Calotropis procera. Pharma Biol 2003, 41:263-265.